The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

被引：1
|
作者：
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ]
Siebenaller, Caitlin [4 ]
Mukherjee, Sudipto [5 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构：
[1] Cleveland Clin, Canc Biostat, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Quantitat Hlth Sci, Dept Quantitat Hlth Sci & Translat Hematol & Onco, Cleveland, OH USA
[4] Cleveland Clin Taussig Canc Inst, Leuekmia Program, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130319
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy
    Lee, Sangmin
    Ritchie, Ellen K.
    Miah, Sumaiya
    Andy, Caroline
    Curcio, Tania
    Goudy, Finola
    Hovan, Michael
    Douglass, Claire
    Desai, Pinkal
    Samuel, Michael B.
    Roboz, Gail J.
    Satlin, Michael
    BLOOD, 2019, 134
  • [32] THE ROLE OF CYTOGENETICS IN DETERMINING INDUCTION OUTCOME AND REMISSION DURATION OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    RAZA, A
    UCAR, K
    BLOCK, AW
    LARSON, R
    PREISLER, H
    SANDBERG, AA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 30 - 30
  • [33] Adding Oral Pioglitazone to Standard Induction Chemotherapy of Acute Myeloid Leukemia: A Randomized Clinical Trial
    Ghadiany, Mojtaba
    Tabarraee, Mahdi
    Salari, Sina
    Haghighi, Shirin
    Rezvani, Hamid
    Ghasemi, Seyedeh Najmeh
    Karimi-Sari, Hamidreza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (04): : 206 - 212
  • [34] Mathematical models to identify combined protein and clinical biomarkers of response to induction chemotherapy in acute myeloid leukemia (AML)
    Tibes, Raoul
    Meurice, Natalie
    Anthony, Steven P.
    Qiu, YiHua
    Komblau, Steven M.
    Mousses, Spyro
    Petit, Joachim
    BLOOD, 2007, 110 (11) : 708A - 708A
  • [35] Psychological mobile app for patients with acute myeloid leukemia (AML): A pilot randomized clinical trial
    El-Jawahri, Areej
    Luskin, Marlise R.
    Greer, Joseph A.
    Traeger, Lara
    Lavoie, Mitchell
    Vaughn, Dagny Marie
    Andrews, Stephanie
    Yang, Daniel
    Boateng, Kofi Y.
    Newcomb, Richard A.
    Ufere, Nneka N.
    Fathi, Amir T.
    Hobbs, Gabriela
    Brunner, Andrew
    Abel, Gregory A.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Temel, Jennifer S.
    CANCER, 2023, 129 (07) : 1075 - 1084
  • [36] Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial
    Quarello, Paola
    Fagioli, Franca
    Basso, Giuseppe
    Putti, Maria C.
    Berger, Massimo
    Luciani, Matteo
    Rizzari, Carmelo
    Menna, Giuseppe
    Masetti, Riccardo
    Locatelli, Franco
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 566 - 573
  • [37] Psychological mobile app for patients with acute myeloid leukemia (AML): A randomized clinical trial.
    El-Jawahri, Areej
    Luskin, Marlise Rachael
    Greer, Joseph A.
    Lavoie, Mitchell W.
    Vaughn, Dagny
    Yang, Daniel
    Boateng, Kofi
    Newcomb, Richard
    Fathi, Amir Tahmasb
    Hobbs, Gabriela
    Brunner, Andrew Mark
    Abel, Gregory A.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Temel, Jennifer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Fluconazole Prophylaxis and Invasive Fungal Infections in Patients Receiving Induction/Consolidation Chemotherapy for Acute Myeloid Leukemia
    Kodali, S.
    Jehangir, W.
    Umyarova, E.
    Cade, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 156 - 156
  • [39] Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
    Etienne, Anne
    Esterni, Benjamin
    Charbonnier, Aude
    Mozziconacci, Marie-Joelle
    Arnoulet, Christine
    Coso, Diane
    Puig, Brigitte
    Gastaut, Jean-Albert
    Maraninchi, Dominique
    Vey, Norbert
    CANCER, 2007, 109 (07) : 1376 - 1383
  • [40] Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (32) : 3609 - 3621
12345